Cutaneous microdialysis: Cytokine evidence for altered innate reactivity in the skin of psoriasis patients?

AAPS Journal

Volumn 14, Issue 2, 2012, Pages 187-195

  Sjögren, Florence ^a   Davidsson, Karin ^a   Sjöström, Michael ^b   Anderson, Chris D ^a,c  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cytokines; Dermis; Human; Microdialysis; Multivariate time series analysis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE REPORT; CHEMOMETRICS; CONTROLLED STUDY; CUTANEOUS MICRODIALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIALYSATE LEVEL; FEASIBILITY STUDY; FEMALE; HUMAN; IMMUNOASSAY; INNATE IMMUNITY; MALE; MICRODIALYSIS; PATIENT MONITORING; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PSORIASIS; REFERENCE VALUE; SKIN DEFECT; TH1 CELL; TH2 CELL; TIME SERIES ANALYSIS; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; ADULT; CYTOKINES; FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNITY, INNATE; MALE; MICRODIALYSIS; MIDDLE AGED; PSORIASIS; SKIN;

EID: 84860738832     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-012-9331-z     Document Type: Article

References (54)

1. Christophers E, Mrowietz U. The inflammatory infiltrate in psoriasis. Clin Dermatol. 1995;13:131-5.
2. Gelfand J, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ, et al. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol. 2004;51:704-8. (Pubitemid 39516879)
3. Nestle F, Kaplan D, Barker J. Psoriasis. N Engl J Med. 2009;361:496-509.
4. Sabat R, Sterry W, Philipp S, Wolk K. Three decades of psoriasis research: where has it led us? Clin Dermatol. 2007;25:504-9. (Pubitemid 350087595)
5. Lowes M, Bowcock A, Krueger J. Patogenesis and therapy of psoriasis. Nature. 2007;445(22):866-73.
6. Lowes M, Lew W, Krueger J. Current concepts in the immunopathogenesis of psoriasis. Dermatol Clin. 2004;22:349-69. (Pubitemid 39140767)
7. Nickoloff B. Skin innate immune system in psoriasis: friend or foe. J Clin Invest. 1999;104:1161-4. (Pubitemid 29536283)
8. Nickoloff B. The cytokine network in psoriasis. Arch Dermatol. 1991;127:871-84.
9. Nickoloff B. Cracking the cytokine code in psoriasis. Nat Med. 2007;13(3):242-4. (Pubitemid 46376653)
10. Griffiths C, Christophers E, Barker J, Chalmers R, Chimenti S, Krueger G, et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol. 2007;156:258-62. (Pubitemid 46095952)
11. Anderson C, Andersson T, Boman A, Molander M. Cutaneous microdialysis for the measurement in vivo of the percutaneous absorption of organic solvents. Curr Probl Dermatol. 1996;25:37-46.
12. Anderson C, Svensson C, Sjögren F, Andersson T, Wårdell K. Human in vivo microdialysis technique can be used to measure cytokines in contact reactions. Curr Probl Dermatol. 1995;23:121-30.
13. Averbeck B, Beilharz S, Bauer M, Gebhardt C, Hochleitner K, Kauer F, et al. In situ profiling and quantification of cytokines released during ultraviolet B induced inflammation by combining dermal microdialysis and protein microarrays. Exp Dermatol. 2006;15:447-54.
14. Clough G. Microdialysis of large molecules. AAPS J. 2005;7(3): E686-92.
15. Clough G, Jackson C, Lee J, Jamal S, Church M. What can microdialysis tell us about the temporal and spatial generation of cytokines in allergen induced responses in human skin in vivo. J Invest Dermatol. 2007;234:443.
16. Krogstad A, Jansson P, Gisslèn P, Lönnroth P. Microdialysis methodology for the measurement of dermal interstitial fluid in humans. Br J Dermatol. 1996;134:1005-12. (Pubitemid 26183132)
17. Petersen L, Kristensen J, Bülow J. Microdialysis of the interstitial water space in human skin in vivo: quantitative measurement of cutaneous glucose concentrations. J Invest Dermatol. 1992;99:357-60.
18. Salgo R, Thaci D, Boehncke S, Diehl S, Hoffman M, Boehncke W. Microdialysis documents changes in the micromilieu of psoriatic plaques under continuous systemic therapy. Exp Dermatol. 2011;20:130-3.
19. Sjögren F, Svensson C, Anderson C. Technical prerequisites for in vivo microdialysis determination of interleukin-6 in human dermis. Br J Dermatol. 2002;146(3):375-82. (Pubitemid 34603808)
20. Sjögren F, Anderson C. Sterile trauma to normal human dermis invariably induces IL1b, IL6 and IL8 in an innate response to "danger". Acta Dermatol Venereol. 2009;89:459-465
21. Anderson C, Andersson T, Wårdell K. Changes in skin circulation after insertion of a microdialysis probe visualized by laser Doppler perfusion imaging. J Invest Dermatol. 1994;102:807-11. (Pubitemid 24144267)
22. Groth L, Serup J. Cutaneous microdialysis in man: effects of needle insertion trauma and anaesthesia on skin perfusion, erythema and skin thickness. Acta Derm Venereol. 1998;78 (1):5-9. (Pubitemid 28103669)
23. Anderson C, Andersson T, Andersson R. In-vivo microdialysis estimation of histamine in human skin. Skin Pharmacol. 1992;5:177-83.
24. Sjögren F. Dermal cell trafficking: from microscopy to micro-dialysis [medical]: Linköping: Unitryck Sweden; 2005.
25. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol. 2007;19:3-10. (Pubitemid 46498750)
26. Gallo R, Taylor K, et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependant on Toll-like receptor 4, CD44 and MD-2. J Biol Chem. 2007;282:18265-75. (Pubitemid 47100227)
27. Yamasaki K, Muot J, Taylor K, Cogen A, Audish D, Bertin J, et al. NLRP3/cryopyrin is necessary for interleukin-1b (IL-1b) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem. 2009;284:12762-71.
28. Martinon F, Burns K, Tschopp J. The inflammosome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-B. Mol Cell. 2002;10:417-26. (Pubitemid 35007355)
29. Matzinger P. The danger model: a renewed sense of self. Science. 2002;296:301-5. (Pubitemid 34303674)
30. Watanabe H, Gaide O, Pétrilli V, Martinon F, Contassat E, Roques S, et al. Activation of the IL-1b-processing inflamma-some is involved in contact hypersensitivity. J Invest Dermatol. 2007;127:1956-63. (Pubitemid 47075373)
31. Stenken J, Church M, Gill C, Clough G. How minimally invasive is microdialysis sampling? A cautionary note for cytokine collection in human skin and other clinical studies. AAPS J. 2010;12(1):73-78
32. Sjögren F, Anderson C. Are cutaneous microdialysis cytokine findings supported by end-point biopsy immunohistochemistry findings? AAPS J. 2010;12:741.
33. Barton G. A calculated response: control of inflammation by the innate immune system. J Clin Invest. 2008;118:413-20. (Pubitemid 351206528)
34. Bos J, de Rie M, Teunissen M, Piskin G. Psoriasis: dysregulation of innate immunity. Br J Dermatol. 2005;152:1098-107. (Pubitemid 40933406)
35. Chamian F, Krueger J. Psoriasis vulgaris: an interplay of T lymphocytes, dendritic and inflammatory cytokines in pathogen-esis. Curr Opin Rheumatol. 2009;16(4):331-7. (Pubitemid 38803131)
36. Lowes M. Increase in TNFa and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti CD11a). Proc Natl Acad Sci USA. 2005;102:19057-62. (Pubitemid 43049565)
37. Fulwyler M, McHugh T. Flow microsphere immunoassay for the quantitative and simultaneous detection of multiple soluble analytes. Methods Cell Biol. 1990;33:613-29.
38. Wold S, Kettaneh N, Fridén H, Holmberg A. Modelling and diagnostics of batch processes and analogous kinetic experiments. Chemometr Intell Lab Syst. 1998;44:331-40. (Pubitemid 29016108)
39. Wold S, Sjöström M, Eriksson L. PLS in chemistry. In: Schleyer PvR, Allinger NL, Clark T, Gasteiger J, Kollman PA, Schaefer III HF, et al., editors. The encyclopedia of computational chemistry. Chichester: John Wiley & Sons; 1999. p. 2006-20.
40. Wold S. Cross-validatory estimation of the number of components in factor and principal components models. Technometrics. 1978;20:397-405.
41. Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikström C, S W. Multi and megavariate data analysis, part I basic principles and applications. 2nd ed. Umetrics AB: Umea, Sweden; 2006.
42. Varol A, Seifert O, Anderson C. The skin pathergy test: innately useful? AODR 302:155-168;2010.
43. Florin L, Knebel G, Zingrinao P, Wonderstrass B, Mauch C, Shorpp-Kistner M, et al. Delayed wound healing and epidermal hyperproliferation in mice lacking Jun B in the skin. J Invest Dermatol. 2006;126:902-11.
44. Mascia F, Cataisson C, Lee T, Theadgill D, Mariani V, Amerio P, et al. EGFR regulates the expression of keratinocyte derived granulocyte/macrophage colony-stimulating growth factor in vitro and in vivo. J Invest Dermatol. 2010;130:682-93.
45. Gasson J. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood. 1991;77:1131-45.
46. Sonderegger I, Iezzi G, Maier R, Schmitz N, Kurrer M, Kopf M. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J Exp Med 205:2281-2294; 2008.
47. O'Shea J, Murray P. Cytokine signaling modules in inflammatory responses. J Immunol. 2008;28:477-87. (Pubitemid 351467044)
48. Wilson J, Boniface K, Chan J, Mckenzie B, Blumenschein W, Mattson J, et al. Development, cytokine profile and function of human interleukin 17 producing helper T cells. Nat Immunol. 2007;8(9):950-7. (Pubitemid 47300009)
49. Bonifati C, Carducci M, Cordiali-Fei P, et al. Correlated increases of tumor necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients: relationships with disease severity. Clin Exp Dermatol. 1994;19:383-7. (Pubitemid 24308596)
50. Raychaudhuri S, Jiang W, Raychaudhuri S. Revisiting the Koebner phenomenon role of NGFand its receptor system in the pathogenesis of psoriasis. Am J Pathol. 2008;172:961-71. (Pubitemid 351519993)
51. Nordlind K, Thorslund K, Lonne-Rahm S. Expression of serotonergic receptors in psoriatric skin. Arch Dermatol Res. 2006;298:99-106. (Pubitemid 44341641)
52. Azmi J, Griffin J, Antti H, Shore R, Johansson E, Nicholson J, et al. Metabolic trajectory characterisation of xenobiotic-induced hepatotoxic lesions using statistical batch processing of NMR data. Analyst. 2002;127:271-6. (Pubitemid 34151246)
53. Appay A, van Lier R, Sallusto F, Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry part A. 2008;73A:975-83.
54. Valeyev N, Hundhausen C, Umezawa Y, Kotov N, Williams G, Clop A, et al. A systems model for immune cell interactions unravels the mechanism of inflammation in human skin. PLoS Comput Biol. 2010;6:1-22.